Product Approval Information
Proper Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
Tradename: DAPTACEL
Manufacturer: Sanofi Pasteur, Ltd. License #1726
Package Insert (PDF - 247 KB) - Approved: March 12, 2008
Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.
Date: March 12, 2008
Indication: To include a fifth dose booster immunization at 4 to 6 years of age following four previous doses of DAPTACEL
March 12, 2008 Approval Letter
Committee Chair Approval Memo
Clinical Review (PDF - 178 KB)
Date: May 14, 2002
Indication: Active immunization of infants and toddlers at 2, 4, 6, and 17-20 months of age against diphtheria, tetanus and pertussis
May 14, 2002 Approval Letter
Clinical Review (PDF - 465 KB)